{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:24:24Z","timestamp":1790421864899,"version":"4.1.0"},"reference-count":15,"publisher":"American Diabetes Association","issue":"12","license":[{"start":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T00:00:00Z","timestamp":1630281600000},"content-version":"vor","delay-in-days":2844,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,12,1]]},"abstract":"<jats:p>We studied the change in the first-phase insulin response (FPIR) during the progression to type 1 diabetes (T1D). Seventy-four oral insulin trial progressors to T1D from the Diabetes Prevention Trial\u2013Type 1 with at least one FPIR measurement after baseline and before diagnosis were studied. The FPIR was examined longitudinally in 26 progressors who had FPIR measurements during each of the 3 years before diagnosis. The association between the change from the baseline FPIR to the last FPIR and time to diagnosis was studied in the remainder (n = 48). The 74 progressors had lower baseline FPIR values than nonprogressors (n = 270), with adjustments made for age and BMI. In the longitudinal analysis of the 26 progressors, there was a greater decline in the FPIR from 1.5 to 0.5 years before diagnosis than from 2.5 to 1.5 years before diagnosis. This accelerated decline was also evident in a regression analysis of the 48 remaining progressors in whom the rate of decline became more marked with the approaching diagnosis. The patterns of decline were similar between the longitudinal and regression analyses. There is an acceleration of decline in the FPIR during the progression to T1D, which becomes especially marked between 1.5 and 0.5 years before diagnosis.<\/jats:p>","DOI":"10.2337\/db13-0656","type":"journal-article","created":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T04:26:04Z","timestamp":1374121564000},"page":"4179-4183","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":81,"title":["Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial\u2013Type 1 Participants"],"prefix":"10.2337","volume":"62","author":[{"given":"Jay M.","family":"Sosenko","sequence":"first","affiliation":[{"name":"Division of Endocrinology, University of Miami, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay S.","family":"Skyler","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, University of Miami, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig A.","family":"Beam","sequence":"additional","affiliation":[{"name":"Division of Informatics and Biostatistics, University of South Florida, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P.","family":"Krischer","sequence":"additional","affiliation":[{"name":"Division of Informatics and Biostatistics, University of South Florida, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla J.","family":"Greenbaum","sequence":"additional","affiliation":[{"name":"Benaroya Research Institute at Virginia Mason, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Mahon","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Rafkin","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, University of Miami, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Della","family":"Matheson","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, University of Miami, Miami, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevan C.","family":"Herold","sequence":"additional","affiliation":[{"name":"Department of Immunobiology, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry P.","family":"Palmer","sequence":"additional","affiliation":[{"name":"VA Puget Sound Health Care System, Division of Endocrinology, Metabolism, and Nutrition, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"and the Type 1 Diabetes TrialNet and Diabetes Prevention Trial\u2013Type 1 Study Groups","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2013,11,16]]},"reference":[{"key":"2022031223100400200_B1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00500379","article-title":"Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients","volume":"34","author":"Vardi","year":"1991","journal-title":"Diabetologia"},{"key":"2022031223100400200_B2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0022-3476(87)80192-0","article-title":"Diagnosis of pre-type I diabetes","volume":"111","author":"Chase","year":"1987","journal-title":"J Pediatr"},{"key":"2022031223100400200_B3","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198508223130801","article-title":"First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion","volume":"313","author":"Srikanta","year":"1985","journal-title":"N Engl J Med"},{"key":"2022031223100400200_B4","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.1985.03360110059024","article-title":"Triad of markers for identifying children at high risk of developing insulin-dependent diabetes mellitus","volume":"254","author":"Ginsberg-Fellner","year":"1985","journal-title":"JAMA"},{"key":"2022031223100400200_B5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/diacare.28.5.1068","article-title":"Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1","volume":"28","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031223100400200_B6","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa012350","article-title":"Effects of insulin in relatives of patients with type 1 diabetes mellitus","volume":"346","author":"Diabetes Prevention Trial--Type 1 Diabetes Study Group","year":"2002","journal-title":"N Engl J Med"},{"key":"2022031223100400200_B7","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.cca.2011.07.019","article-title":"Comparison of two insulin assays for first-phase insulin release in type 1 diabetes prediction and prevention studies","volume":"412","author":"Mahon","year":"2011","journal-title":"Clin Chim Acta"},{"key":"2022031223100400200_B8","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.2337\/dc09-0934","article-title":"Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1","volume":"32","author":"Orban","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031223100400200_B9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2337\/db09-1378","article-title":"Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset","volume":"59","author":"Ferrannini","year":"2010","journal-title":"Diabetes"},{"key":"2022031223100400200_B10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2337\/diacare.29.03.06.dc05-1006","article-title":"Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1","volume":"29","author":"Sosenko","year":"2006","journal-title":"Diabetes Care"},{"key":"2022031223100400200_B11","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2337\/dc08-1872","article-title":"Diabetic subjects diagnosed through the Diabetes Prevention Trial-Type 1 (DPT-1) are often asymptomatic with normal A1C at diabetes onset","volume":"32","author":"Triolo","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031223100400200_B12","doi-asserted-by":"crossref","first-page":"620","DOI":"10.2337\/dc09-1770","article-title":"Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 participants","volume":"33","author":"Sosenko","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031223100400200_B13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0168-8227(91)90019-A","article-title":"Familial and sporadic insulin-dependent diabetes: evidence for heterogeneous etiologies?","volume":"14","author":"O\u2019Leary","year":"1991","journal-title":"Diabetes Res Clin Pract"},{"key":"2022031223100400200_B14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/08916939408995692","article-title":"Genetic susceptibility markers in Danish patients with type 1 (insulin-dependent) diabetes\u2014evidence for polygenicity in man","volume":"19","author":"Pociot","year":"1994","journal-title":"Autoimmunity"},{"key":"2022031223100400200_B15","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.2337\/db08-1305","article-title":"Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population","volume":"58","author":"Siljander","year":"2009","journal-title":"Diabetes"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/62\/12\/4179\/568965\/4179.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/62\/12\/4179\/568965\/4179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T16:36:58Z","timestamp":1667407018000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/62\/12\/4179\/33939\/Acceleration-of-the-Loss-of-the-First-Phase"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,16]]},"references-count":15,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,11,16]]},"published-print":{"date-parts":[[2013,12,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db13-0656","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,16]]}}}